Correlation Between Richmond Vanadium and Anatara Lifesciences

Can any of the company-specific risk be diversified away by investing in both Richmond Vanadium and Anatara Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Richmond Vanadium and Anatara Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Richmond Vanadium Technology and Anatara Lifesciences, you can compare the effects of market volatilities on Richmond Vanadium and Anatara Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Richmond Vanadium with a short position of Anatara Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Richmond Vanadium and Anatara Lifesciences.

Diversification Opportunities for Richmond Vanadium and Anatara Lifesciences

0.42

Correlation Coefficient

Richmond Vanadium  Anatara Lifesciences

Very weak diversification

The 3 months correlation between Richmond and Anatara is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Richmond Vanadium Technology and Anatara Lifesciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anatara Lifesciences and Richmond Vanadium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Richmond Vanadium Technology are associated (or correlated) with Anatara Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anatara Lifesciences has no effect on the direction of Richmond Vanadium i.e., Richmond Vanadium and Anatara Lifesciences go up and down completely randomly.

Pair Corralation between Richmond Vanadium and Anatara Lifesciences

Assuming the 90 days trading horizon Richmond Vanadium Technology is expected to under-perform the Anatara Lifesciences. But the stock apears to be less risky and, when comparing its historical volatility, Richmond Vanadium Technology is 1.03 times less risky than Anatara Lifesciences. The stock trades about -0.02 of its potential returns per unit of risk. The Anatara Lifesciences is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  2.50  in Anatara Lifesciences on October 24, 2024 and sell it today you would earn a total of  3.10  from holding Anatara Lifesciences or generate 124.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Richmond Vanadium Technology  vs.  Anatara Lifesciences

Richmond Vanadium

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Richmond Vanadium Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Anatara Lifesciences

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Anatara Lifesciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Anatara Lifesciences is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Richmond Vanadium and Anatara Lifesciences

The main advantage of trading using opposite Richmond Vanadium and Anatara Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Richmond Vanadium position performs unexpectedly, Anatara Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anatara Lifesciences will offset losses from the drop in Anatara Lifesciences' long position.

The idea behind Richmond Vanadium Technology and Anatara Lifesciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.